Company: INMB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001213900-25-073077
Chunk: 89

Company: Inmune Bio, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 2
Chunk 89
---
2001 until the formation of INmune
Bio in 2015, Mr. Moss has invested in healthcare technology companies. Mr. Moss holds an MBA from Rice University and a BA in Economics
from the University of California, San Diego.

37

For serving as the Company’s
President and Chief Executive Officer, Mr. Moss’s compensation paid by the Company will continue at its current amount pursuant
to his previous disclosed employment agreement, between Mr. Moss and the Company, dated January 1, 2021, with an annual base salary of
$408,722 and remain eligible for an annual discretionary bonus with a target amount of 40% of his then current base salary as determined
by the Board and/or compensation committee of the Board in its discretion based upon the achievement of corporate and/or individual objectives
that are determined in the sole discretion of the Board. Mr. Moss will not receive any additional compensation for serving as a member
of the Board. The terms of employment of Mr. Moss as the Company’s President and Chief Executive Officer will be revisited by the
Compensation Committee and the Board and disclosed to the market in the future.

There are no arrangements
or understandings between Mr. Moss and any other persons pursuant to which he was elected as an officer or director. Mr. Moss does not
have any family relationships with any of the Company’s directors or executive officers. There are no transactions involving the
Company and Mr. Moss that the Company would be required to report pursuant to Item 404(a) of Regulation S-K.

Appointment of Interim
Chief Financial Officer 

On August 4, 2025, the Board
appointed Cory Ellspermann as Interim Chief Financial Officer of the Company, effective immediately.

Mr. Ellspermann, age 53, has served as our Interim
Chief Financial Officer since August 2025. Prior to Mr. Ellspermann’s appointment as our Interim Chief Financial Officer, Mr. Ellspermann
served as our Controller and VP of Finance since June 2019. Mr. Ellspermann possesses nearly 30 years of financial management experience
at public and private companies. Prior to joining us, Mr. Ellspermann was Senior Accounting Manager at Artivest, an alternative investments
company. He is a certified public accountant in the State of Texas and previously served as a Senior Audit Manager at Ernst & Young.
He holds a BS in Accounting from Purdue University.

Effective upon his appointment
as Inter